Sihuan raises $715 million in Hong Kong listing
This article was originally published in Scrip
Executive Summary
Sihuan Pharmaceutical Holdings Group, the Chinese cardio- and cerebrovascular pharmaceuticals company, raised HK$5.5 billion ($715 million) in an IPO on the Hong Kong Stock Exchange. The company offered 1.25 billion shares at HK$4.60 each and was heavily over-subscribed.